about
Abi1/Hssh3bp1 pY213 links Abl kinase signaling to p85 regulatory subunit of PI-3 kinase in regulation of macropinocytosis in LNCaP cellsControl region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinomaControl of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkheadPI3K p110δ is expressed by gp38(-)CD31(+) and gp38(+)CD31(+) spleen stromal cells and regulates their CCL19, CCL21, and LTβR mRNA levelsA PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis.Phosphoinositide 3-kinase β regulates chromosome segregation in mitosis.PI3K p110γ deletion attenuates murine atherosclerosis by reducing macrophage proliferation but not polarization or apoptosis in lesions.p85beta phosphoinositide 3-kinase regulates CD28 coreceptor functionPhosphoinositide 3-kinase controls early and late events in mammalian cell divisionNuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survivalPhosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entryThymic selection.A promoter DNA demethylation landscape of human hematopoietic differentiation.p85β phosphoinositide 3-kinase subunit regulates tumor progressionPhosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation.Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.Specific function of phosphoinositide 3-kinase beta in the control of DNA replication.Tyrosine kinase specific motif at subdomain VIII does not confer specificity for tyrosine.Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.Phosphoinositide 3-kinase beta controls replication factor C assembly and function.Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells.PI3Kgamma activation by CXCL12 regulates tumor cell adhesion and invasion.A cAMP-activated pathway, including PKA and PI3K, regulates neuronal differentiation.The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras.A new role for the p85-phosphatidylinositol 3-kinase regulatory subunit linking FRAP to p70 S6 kinase activation.Phosphoinositide 3-kinase beta protects nuclear envelope integrity by controlling RCC1 localization and Ran activity.p85β increases phosphoinositide 3-kinase activity and accelerates tumor progression.Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate.Forkhead transcription factors contribute to execution of the mitotic programme in mammals.Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis.A Role for phosphoinositide 3-kinase in the control of cell division and survival during retinal development.Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing.TOR signaling in mammals.Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus.p56lck phosphorylation by Ca2+/calmodulin-dependent protein kinase type II.PTEN regulates motility but not directionality during leukocyte chemotaxis.Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death.CXCL12-mediated murine neural progenitor cell movement requires PI3Kβ activation.
P50
Q24337290-BF6503DF-4415-4445-B14F-FBF611453ED9Q24804325-DACF14D6-5144-4795-A43F-9FC3B5BFAA58Q28506168-7B1CF9A5-6E49-4785-8C6F-F6468C5FFA6CQ28512141-7122F0D6-D92D-4AB3-8532-42F1819342D2Q30478155-2F7E1966-A2B8-45B7-AE88-5B4B608F2688Q30528812-C0BA3207-B015-4ED5-AE8E-CB6EA7623555Q31133175-6EB1B50A-5164-4638-BD1B-CEC33A040C65Q34156303-D009673E-4358-4362-9B11-F5658B010407Q34410971-717677C2-9A23-46D1-BC40-1A330B81DBB2Q35096551-280124E1-5369-4251-BF90-63A2FF762CC1Q35131676-3B6EC1E1-1BCF-48B9-9FE8-BB8E1437DA33Q35257647-6092F6BB-D5AA-4EA2-A949-06F2F99E9E18Q35633573-F6F97424-485D-46D0-A5A6-56E49576CF65Q36094306-4E985BD6-1663-45F5-8A88-8FCB605B46C1Q36229227-7DCB2AFC-2670-4943-9DA2-174753743180Q36540331-E9E89933-8BDB-4781-8B3E-CEEE0B6668C7Q37183054-71EBF89D-47D8-4E00-95B6-48A703CCCD60Q38301362-975A1D51-51EA-480D-AA05-1243D882F043Q38981868-15DF68FB-38A3-4D90-9CA5-AFA57C6E3010Q39240233-9E874354-EDEB-4D00-916A-3C09CFFD1605Q39273551-CBC031D8-6E17-4BC4-9520-62DF888CC840Q39816036-E84AF2F0-FD54-4021-81C6-60745F91D0B5Q40619306-76F232FA-34CE-4628-A053-57A96CA0D863Q40708569-E3DE24DD-3C68-4C85-A827-9CCC39771D61Q40771721-E982B891-CD32-4969-B76A-F04E13ED8AE7Q42015294-CDFD293B-D2B5-47D5-A000-69D632705508Q42410139-E864CAE7-0994-406B-A226-2366281CDF2DQ42802805-A49AE585-EC4C-4083-AF02-7D954E0CFE93Q42824525-1AB3B896-B8E2-4BF3-87B2-0968D5A727CAQ43569584-E33CB2AE-640E-4A08-840E-676D79DC160CQ44042834-3F06D77E-8715-4E65-A979-485701024816Q45051974-6EE662B3-7052-43C6-AE6E-C0833C12B94DQ45061881-90A49275-D740-403E-9814-AD8081AF4B79Q46087043-C7DEAC65-3F38-47C5-857B-BD1786F8237BQ46674138-19214399-02AB-4AA2-9EA0-444FAFD5EDC4Q48189834-4BD68D54-7D2C-42B5-ACCA-9A7659080989Q50785516-B6E5E4B4-1BC8-439C-8398-9825881DF197Q50798715-22EAF432-6DF5-4492-AF8F-C8B232EBF38AQ50997716-9EF52423-C0E0-4402-AC3D-349B9713EEE6Q51054172-15678ECE-4D48-4A2A-A5CF-61521A863F25
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana C. Carrera
@ast
Ana C. Carrera
@en
Ana C. Carrera
@es
Ana C. Carrera
@nl
type
label
Ana C. Carrera
@ast
Ana C. Carrera
@en
Ana C. Carrera
@es
Ana C. Carrera
@nl
prefLabel
Ana C. Carrera
@ast
Ana C. Carrera
@en
Ana C. Carrera
@es
Ana C. Carrera
@nl
P106
P1153
7006396921
P21
P31
P496
0000-0002-3999-5434